Daikenchuto (TU‐100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K

Many pharmaceutical agents not only require microbial metabolism for increased bioavailability and bioactivity, but also have direct effects on gut microbial assemblage and function. We examined the possibility that these actions are not mutually exclusive and may be mutually reinforcing in ways tha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacol Res Perspect
Main Authors: Hasebe, Takumu, Ueno, Nobuhiro, Musch, Mark W., Nadimpalli, Anuradha, Kaneko, Atsushi, Kaifuchi, Noriko, Watanabe, Junko, Yamamoto, Masahiro, Kono, Toru, Inaba, Yuhei, Fujiya, Mikihiro, Kohgo, Yutaka, Chang, Eugene B.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4777267/
https://ncbi.nlm.nih.gov/pubmed/26977303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.215
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados